• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX PRO TRIFOCAL UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON PANOPTIX PRO TRIFOCAL UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM; INTRAOCULAR LENS Back to Search Results
Model Number PXCAT0
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Disturbances (2140); Halo (2227)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A product was not returned for analysis.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non-health care professional reported that following an intraocular lens (iol) implant procedure, the patient was able to see distance one day later the surgery.After a week since surgery she cannot read or see near and experienced blurry vision.At night the halos around every light source are significant.About 4-5 rings around headlights and streetlights.It makes it difficult to read street signs.Additional information was received and stated, patient also experienced blurry vision at intermediate distance and severe starburst around light sources at night.At one week post-operative visit the eye looks healthy and seems to be healing with very little swelling and doctor suggested using dry eye moisturizing drops.
 
Additional Manufacturer Narrative
Additional information was provided in b.5.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information was received and stated, patient said she was 7 weeks from the surgery and still cannot clearly see and her doctor said that she had healed well.The distance vison was good but letters are blurry and cannot read street signs, the intermediate vision can make out the letters but blurry at close and cannot read any letters.In nighttime there was halos and starburst making it very difficult to drive.She was waiting for another month to see if the vision gets better and will not have surgery on her second eye.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX PRO TRIFOCAL UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key23803656
Report Number9612169-2025-02515
Device Sequence Number13108776
Product Code HQL
UDI-Device Identifier00380658490263
UDI-Public(01)00380658490263(17)300405(11)250407(10)26007858
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 01/27/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberPXCAT0
Device Catalogue NumberPXCAT0.160
Device Lot Number26007858
Was Device Available for Evaluation? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 11/24/2025
Supplement Date Received by Manufacturer01/07/2026
Initial Report FDA Received Date12/15/2025
Supplement Report FDA Received Date01/27/2026
Date Device Manufactured04/07/2025
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age72 YR
Patient SexFemale
-
-